Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-02-07

FDA Approved: PILOCARPINE HYDROCHLORIDE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for pilocarpine hydrochloride submitted by Sandoz Inc, resulting in a labeling update for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pilocarpine hydrochloride (Pilocarpine hydrochloride)

Snippet

SUPPL AP for PILOCARPINE HYDROCHLORIDE (PILOCARPINE HYDROCHLORIDE)